ImmunityBio, Inc. Total Revenue

• ImmunityBio, Inc. showed an increase of +668.3% in Total Revenue from 2024 to 2025.
• This data is from ImmunityBio, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
• XBRL data for this metric is available from 2013 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2014: $286.0 thousand | Q2 2014: $124.0 thousand | Q3 2014: $133.0 thousand | Q4 2014: $98.0 thousand | Q1 2015: $120.0 thousand | Q2 2015: $91.0 thousand | Q3 2015: $10.0 thousand | Q4 2015: $15.0 thousand | Q1 2016: $6.0 thousand | Q2 2016: $12.0 thousand | Q3 2016: $12.0 thousand | Q4 2016: $14.0 thousand | Q1 2017: $11.0 thousand | Q2 2017: $14.0 thousand | Q3 2017: $8.0 thousand | Q4 2017: $12.0 thousand | Q1 2018: $5.0 thousand | Q2 2018: $4.0 thousand | Q3 2018: $31.0 thousand | Q4 2018: $7.0 thousand | Q1 2019: $5.0 thousand | Q2 2019: $17.0 thousand | Q3 2019: $12.0 thousand | Q4 2019: $9.0 thousand | Q1 2020: $165.0 thousand | Q2 2020: $436.0 thousand | Q3 2020: $151.0 thousand | Q4 2020: $21.0 thousand | Q1 2021: $139.0 thousand | Q2 2021: $339.0 thousand | Q3 2021: $66.0 thousand | Q1 2022: $14.0 thousand | Q2 2022: $35.0 thousand | Q3 2022: $118.0 thousand | Q1 2023: $360.0 thousand | Q2 2023: $41.0 thousand | Q2 2023: $41.0 thousand | Q3 2023: $82.0 thousand | Q3 2023: $82.0 thousand | Q1 2024: $40.0 thousand | Q1 2024: $40.0 thousand | Q2 2024: $1.05 million | Q3 2024: $6.11 million | Q1 2025: $16.52 million | Q2 2025: $26.43 million | Q3 2025: $32.06 million.
• Over the full 15 years of available data (2013 to 2025), ImmunityBio, Inc.'s Total Revenue has grown by 18,781.3%.
• Historical annual values: Fiscal year 2025: $113.29 million | Fiscal year 2024: $14.75 million | Fiscal year 2023: $622.0 thousand | Fiscal year 2023: $622.0 thousand | Fiscal year 2022: $240.0 thousand | Fiscal year 2022: $240.0 thousand | Fiscal year 2021: $934.0 thousand | Fiscal year 2020: $605.0 thousand | Fiscal year 2019: $2.20 million | Fiscal year 2018: $47.0 thousand | Fiscal year 2017: $45.0 thousand | Fiscal year 2016: $44.0 thousand | Fiscal year 2015: $236.0 thousand | Fiscal year 2014: $641.0 thousand | Fiscal year 2013: $600.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026